Kane Biotech Inc. ("Kane Biotech" or "Kane") today announced new clinical and pre-clinical data demonstrating the performance of its FDA-cleared revyve® Antimicrobial Wound Gel and revyve Wound Gel ...
Changes strategically aligned to support planned launch of Anaphylm™ (dibutepinephrine) Sublingual Film, if approved by the FDA, and to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback